{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:59:43Z","timestamp":1791413983707,"version":"4.3.3"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ejogrb.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,11,19]],"date-time":"2016-11-19T12:32:53Z","timestamp":1479558773000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results"],"prefix":"10.1016","volume":"208","author":[{"given":"Herv\u00e9","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Patr\u00edcia Freitas","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Arriagada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejogrb.2016.11.003_bib0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Uterine myomas: an overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Am Coll Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.11.003_bib0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/modpathol.2008.19","article-title":"The spectrum of endometrial pathology induced by progesterone receptor modulators","volume":"21","author":"Mutter","year":"2008","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.11.003_bib0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.ejogrb.2016.11.003_bib0020","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/01.AOG.0000210640.86628.ff","article-title":"Hysterectomy rates for benign indications","volume":"107","author":"Jacobson","year":"2006","journal-title":"Am Coll Obstet Gynecol"},{"issue":"16","key":"10.1016\/j.ejogrb.2016.11.003_bib0025","first-page":"0","article-title":"Rate, type and cost of invasive interventions for uterine myomas in Germany, France and England","volume":"4","author":"Fernandez","year":"2009","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ejogrb.2016.11.003_bib0030","series-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroid (Review)","author":"Lethaby","year":"2007"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.11.003_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0029-7844(95)00102-W","article-title":"GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial","volume":"86","author":"Stovall","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.11.003_bib0040","unstructured":"Prostap SmPC. http:\/\/www.medicines.org.uk\/EMC\/medicine\/2237\/SPC\/Prostap+3+Leuprorelin+Acetate+Depot+Injection+11.25mg\/."},{"issue":"May (2)","key":"10.1016\/j.ejogrb.2016.11.003_bib0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1479-828X.2001.tb01198.x","article-title":"An evidence-based guideline for the management of uterine fibroids","volume":"41","author":"Farquhar","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2016.11.003_bib0050","doi-asserted-by":"crossref","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with selective progesterone receptor modulator, ulipristal acetate","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejogrb.2016.11.003_bib0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2016.11.003_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejogrb.2016.11.003_bib0065","doi-asserted-by":"crossref","first-page":"e0130861","DOI":"10.1371\/journal.pone.0130861","article-title":"Impact of preoperative anaemia and blood transfusion on postoperative outcome in Gynaecological surgery","volume":"10","author":"Richards","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2016.11.003_bib0070","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2016.11.003_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2016.11.003_bib0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2014.10.038","article-title":"Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids","volume":"103","author":"Donnez","year":"2015","journal-title":"Fertil Steril"},{"issue":"1365","key":"10.1016\/j.ejogrb.2016.11.003_bib0085","first-page":"12","article-title":"Individualizing management of fibroids in the perimenopause","volume":"22","author":"Murji","year":"2015","journal-title":"Menopause"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516310156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516310156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:38:39Z","timestamp":1759556319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211516310156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":17,"alternative-id":["S0301211516310156"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.11.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727042001.793531228","asserted-by":"object"}]},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}